(Q39474471)

12 September 2017

title

Superficial granulomatous pyoderma: clinicopathologic spectrum (English)

1 reference

12 September 2017

S R Quimby

1

1 reference

12 September 2017

L E Gibson

series ordinal

2

1 reference

12 September 2017

R K Winkelmann

series ordinal

3

1 reference

12 September 2017

language of work or name

English

0 references

publication date

1 January 1989

1 reference

12 September 2017

1 reference

12 September 2017

volume

64

1 reference

12 September 2017

issue

1

1 reference

12 September 2017

page(s)

37-43

1 reference

Superficial granulomatous pyoderma: A localized vegetative form of pyoderma gangrenosum

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965301-4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965301-4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965301-4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965301-4

Pyoderma gangrenosum involving the head and neck

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965301-4

Pyoderma gangrenosum vs malignant pyoderma. Lumpers vs splitters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965301-4

PYODERMA GANGRENOSUM AS THE PRESENTING SIGN OF REGIONAL ILEITIS: OBSERVATIONS REGARDING THE PATHOGENESIS OF THE SKIN LESIONS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965301-4

Dermatological manifestations of crohn's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965301-4

Pyoderma gangrenosum and Crohn's disease. Eight cases and a review of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965301-4

Pyoderma gangrenosum: a reappraisal of associated systemic diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965301-4

Pyoderma gangrenosum and chronic persistent hepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965301-4

Pyoderma gangrenosum and monoclonal gammopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965301-4

Pyoderma gangrenosum and sarcoidosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965301-4

Recurrent pyoderma gangrenosum and agnogenic myeloid metaplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965301-4

Pyoderma gangrenosum: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965301-4

Diaminodiphenylsulfone and steroids in the treatment of pyoderma gangrenosum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965301-4

Pyoderma gangrenosum: successful treatment with intralesional steroids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965301-4

The treatment of pyoderma gangrenosum with sodium cromoglycate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965301-4

Clofazimine. A new agent for the treatment of pyoderma gangrenosum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965301-4

Pyoderma gangrenosum treated with clofazimine. Report of three cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965301-4

Intralesional steroid therapy of pyoderma gangrenosum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2965301-4

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0025-6196(12)65301-4

1 reference

release_i2vby3ux3bbpbka77ytzuluwx4

12 September 2017

Fatcat ID

0 references

1 reference